Current Clinical Trials for Gynecologic

GCC 1054 - Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)

GCC 1120 - A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women with Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers

GOG 0212 - A RANDOMIZED PHASE III TRIAL OF MAINTENANCE CHEMOTHERAPY Comparing 12 Monthly Cycles Of Single Agent Paclitaxel Or CT-2103 vs. No Treatment Until Documented Relapse In Women With Advanced Ovarian, Primary Peritoneal Or Fallopian Tube Cancer Who Achieve A Complete Clinical Response To Primary Platinum/Taxane Chemotherapy

GOG 0229K - A Phase II Evaluation of BIBF 1120 in The Treatment Of Recurrent Or Persistent Endometrial Carcinoma

GOG 0249 - A Phase III Trial of Pelvic Radiation Therapy vs. Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carbplatin Chemotherapy In Patients With High-Risk, Early Stage Endometrial Carcinoma

GOG 0250 - A Randomized Phase III Evaluation of Docetaxel and Gemcitabine plus G-CSF with Bevacizumab vs. Docetaxel and Gemcitabine plus G-CSF with Placebo in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus.

GOG 0261 - A RANDOMIZED PHASE III TRIAL OF PACLITAXEL PLUS CARBOPLATIN VERSUS IFOSFAMIDEPLUS PACLITAXEL IN CHEMOTHERAPY- NAIVE PATIENTS WITH NEWLY DIAGNOSED STAGE I-IV, PERSISTENT OR RECURRENT CARCINOSARCOMA (MIXED MESODERMAL TUMORS) OF THE UTERUS OR OVARY

GOG 0274 - A PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY AS PRIMARY TREATMENT FOR LOCALLY ADVANCED CERVICAL CANCER COMPARED TO CHEMORADIATION ALONE: THE OUTBACK TRIAL

Email this Page                                                                     Print this Page